Please complete this 2-minute survey to help us improve our products and services:
Community for Open Antimicrobial Drug Discovery (CO-ADD)
CO-ADD is a global open-access screening initiative to uncover significant and rich chemical diversity held outside of corporate screening collections. CO-ADD provides unencumbered free antimicrobial screening for any interested academic researcher. CO-ADD has been recognised as a novel approach in the fight against superbugs by the Wellcome Trust, who have provided funding through their Strategic Awards initiative. Chemists in academia and research organisations have compounds ‘sitting on shelves’ that were not designed as antibiotics and would not otherwise be screened for antimicrobial activity. These compound libraries are screened at no cost against a key panel of drug-resistant bacterial strains. So far we have screened over 80,000 compounds from 35 countries.
Key science sectors
Facilities and major equipment
- Robotic Screening Equipment
- Microbiology Facility
- Cell Biology Facility
- Compound Handling Facilities for medium to high throughput screening
- Analytical LC/MS (ELSD)
- Preparative HPLC
- Rotational Vacuum Concentrator (RVC)
- Analytical NMR
- Robotics for liquid handling
- Murine efficacy models
Number of research staff
Upto 20 research staff
Level 7N, Queensland Bioscience Precinct, Building 80, St Lucia QLD 4072, Australia
Is this your centre? See any issues? Send a request to update your listing.
Register your centre
Register your centre to be listed in this directory.